1ST INTERNATIONAL SYMPOSIUM ON HORMONAL CARCINOGENESIS

该提案要求为第一个 激素致癌作用国际研讨会将于 墨西哥坎昆凯悦酒店，1991年3月19日至23日。 意图是本 将是一系列（每3-4年）研讨会的第一个， 汇集多学科的参与者，分享他们的 关于明显复杂的机制的最新研究结果和当前观点 与激素致癌有关 其中一个独特的特点是， 研讨会是会议记录将出版一本书， 章（口头介绍）或来文（海报介绍）， 斯普林格出版社，并将有助于集中注意这一非常及时 这将有助于更广泛地传播最新的研究报告 在这个复兴的地区。 为科学计划而聚集的是 最权威的国际调查人员在该领域，它是 预计它们将提供积极的讨论和交流。 的 将涉及以下主题：1）致癌风险评估 性激素（派克，卢西尔，李，艾萨克斯）; 2）激素，细胞 增殖和致癌作用（Gorski，Mauvais-Jarvis，Baldi， Beattie，南迪）; 3）雌激素代谢和致癌性（Conney， Metzler，Siiteri，Guengerich，Li）; 4）激素与肿瘤促进 （Lerner，Gustafsson，Yaeger，Ito，McLachlan）; 5）生长因子和 癌基因（Barrett，Groner，DiAugustine，Norris，Stancel）; 6） 雄激素/孕激素致癌作用（Bardin，Ho，安德森，Charreau）。

This proposal requests support funds for the First International Symposium on Hormonal Carcinogenesis to be held at the Hyatt Regency Cancun, Mexico, March 19-23-1991. It is intended that this will be the first in a series (every 3-4 years) of Symposia that will bring together a multidisciplinary group of participants to share their recent findings and current views on the evidently complex mechanism(s) involved in hormonal carcinogenesis. One of the unique features of this Symposium is that the proceedings will be published in a book, either chapter (oral presentations) or communications (poster presentations), by Springer-Verlag and will serve to focus attention on this very timely field and will allow for a wider dissemination of the most recent studies in this resurging area. Assembled for the scientific program are the most authoritive international investigators in the filed and it is anticipated they will provide for vigorous discussion and exchange. The following topics will be represented: 1) Carcinogenesis risk assessment of sex hormones (Pike, Lucier, Li, Isaacs); 2) Hormones, cell proliferation, and carcinogenesis (Gorski, Mauvais-Jarvis, Baldi, Beattie, Nandi); 3) Estrogen metabolism and carcinogenicity (Conney, Metzler, Siiteri, Guengerich, Li); 4) Hormones and tumor promotion (Lerner, Gustafsson, Yaeger, Ito, McLachlan); 5) Growth factors and oncogenes (Barrett, Groner, DiAugustine, Norris, Stancel); 6) Androgen/Progestin carcinogenesis (Bardin, Ho, Anderson, Charreau).